Symptom relief of leiomyomatosis peritonealis disseminata with ulipristal acetate

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
03:30

Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy

Published on: October 25, 2024

2.7K

Jasper Verguts1, Guy Orye2, Sophie Marquette2

  • 1Department of Obstetrics and Gynecology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium ; Department of Obstetrics and Gynecology, University Hospital KU Leuven Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium.

Gynecological Surgery
|March 11, 2014
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Leiomyomatosis peritonealis disseminataMyomaNodulesUlipristal

More Related Videos

Isolation and Characterization of the Murine Uterosacral Ligaments and Pelvic Floor Organs05:47

Isolation and Characterization of the Murine Uterosacral Ligaments and Pelvic Floor Organs

Published on: March 3, 2023

2.2K
Development of a Uterosacral Ligament Suspension Rat Model08:58

Development of a Uterosacral Ligament Suspension Rat Model

Published on: August 17, 2022

7.9K

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K